e-learning
resources
Munich 2006
Sunday 03.09.2006
Monitoring airway inflammation – exhaled markers
vs
induced sputum
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
F. L. Dente, E. Garbella, E. Bacci, S. Cianchetti, A. DiFranco, E. Masino, P. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Session:
Monitoring airway inflammation – exhaled markers
vs
induced sputum
Session type:
Oral Presentation
Number:
744
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. L. Dente, E. Garbella, E. Bacci, S. Cianchetti, A. DiFranco, E. Masino, P. Paggiaro (Pisa, Italy). Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics. Eur Respir J 2006; 28: Suppl. 50, 744
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Eosinophilic inflammation in sputum of poorly controlled asthmatics
Source: Eur Respir J 2002; 20: 1370-1377
Year: 2002
Mechanisms of noneosinophilic asthma
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004
Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity
Source: Eur Respir J 2003; 22: 484-490
Year: 2003
Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002
Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Inflammatory cell activation in eosinophilic and non-eosinophilic asthma
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003
Noninvasive assessment of inflammation in severe asthma
Source: Eur Respir Mon 2011; 51: 208-217
Year: 2011
Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept